Donna K. Davison

Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus

John J. Dwyer, Karen L. Wilson, Donna K. Davison et al. · Proceedings of the National Academy of Sciences · 2007 · 239 citations · Full text

Characterization of determinants of genotypic and phenotypic resistance to enfuvirtide in baseline and on-treatment HIV-1 isolates

Prakash Sista, Tom Melby, Donna K. Davison et al. · AIDS · 2004 · 154 citations

Impact of Human Immunodeficiency Virus Type 1 gp41 Amino Acid Substitutions Selected during Enfuvirtide Treatment on gp41 Binding and Antiviral Potency of Enfuvirtide In Vitro

Mike Mink, Sarah Mosier, S. Janumpalli et al. · Journal of Virology · 2005 · 129 citations · Full text

Antiviral Potency, Susceptibility Decreases, Gp41 Binding +15

Protection of MN-rgp120-Immunized Chimpanzees from Heterologous Infection with a Primary Isolate of Human Immunodeficiency Virus Type 1

Phillip W. Berman, Krishna K. Murthy, Terri Wrin et al. · The Journal of Infectious Diseases · 1996 · 100 citations · Full text

Immunology, Pathology, Strain Mn +17

Tropism-independent protection of macaques against vaginal transmission of three SHIVs by the HIV-1 fusion inhibitor T-1249

Ronald S. Veazey, Thomas A. Ketas, Per Johan Klasse et al. · Proceedings of the National Academy of Sciences · 2008 · 43 citations · Full text

Sexual Health, Human Retrovirus, Immunology +13